Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2025-12-26 @ 2:24 PM
Study NCT ID:
NCT00582166
Status:
TERMINATED
Last Update Posted:
2019-12-13
First Post:
2007-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ibritumomab Tiuxetan (Zevalin)+ Rituximab Maintenance
Sponsor:
University of Wisconsin, Madison
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01-25
Start Date Type:
ACTUAL
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-19
First Submit QC Date:
None
Study First Post Date:
2007-12-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-11-16
Results First Submit QC Date:
None
Results First Post Date:
2018-07-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-11
Last Update Post Date:
2019-12-13
Last Update Post Date Type:
ACTUAL